The effect of the duration of clopidogrel use on hsCRP levels after stenting the target vessel in patients with acute coronary syndrome

被引：0
|
作者：
Cekici, Y. [1 ]
Korkmaz, H. [1 ]
Akbulut, M. [2 ]
Celik, A. [1 ]
机构：
[1] Elazig Educ & Res Hosp, Elazig, Turkey
[2] Firat Univ, TR-23169 Elazig, Turkey
来源：
EUROPEAN HEART JOURNAL | 2011年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [21] Comparison of low-dose versus high-dose atorvastain in clopidogrel resistance after coronary stenting in patients with acute coronary syndrome
    Hong, S. J.
    Shim, W. J.
    Park, S. M.
    Joo, H. J.
    Shin, S. Y.
    Choi, J. I.
    Park, J. Y.
    Kim, K. A.
    Lim, D. S.
    EUROPEAN HEART JOURNAL, 2007, 28 : 194 - 194
  • [22] Comparison of atorvastain 10mg versus 40mg in clopidogrel, resistance after coronary stenting in patients with acute coronary syndrome
    Hong, Soon Jun
    Park, Ji-Young
    Kim, Kvoung-Ah
    Choi, Jong Il
    Joo, Hyung Joon
    Shin, Seung Yong
    Shim, Wan Joo
    Park, Seong Mi
    Lim, Sang Yup
    Lim, Do-Sun
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 70L - 70L
  • [23] hsCRP is an independent predictor of cardiovascular events in diabetic patients after coronary stenting
    Angiolillo, D. J.
    Sabate, M.
    Jimenez-Quevedo, P.
    Bernardo, E.
    Ramirez, C.
    Fernandez-Ortiz, A.
    Macaya, C.
    EUROPEAN HEART JOURNAL, 2005, 26 : 648 - 648
  • [24] Prior clopidogrel use and outcome of acute coronary syndrome
    Soiza, Roy L.
    Leslie, Stephen J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2006, 111 (02) : 313 - 314
  • [25] Clopidogrel, prasugrel, or ticagrelor use and clinical outcome in patients with acute coronary syndrome
    Rezaei, S.
    Geroldinger, A.
    Heinze, G.
    Reinhardt, B.
    Wolzt, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S392 - S392
  • [26] A follow-up study of clopidogrel, prasugrel, or ticagrelor use in patients with acute coronary syndrome after acute coronary syndrome in Austria from 2015 to 2017
    Rezaei, S. Sheikh
    Andreas, G.
    Reichardt, B.
    Wolzt, M.
    WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S302 - S302
  • [27] Low platelet response to clopidogrel increased the risk of recurrent atherothrombotic events in patients with non-ST acute coronary syndrome after coronary stenting
    Cuisset, T.
    Frere, C.
    Quilici, J.
    Morange, P. E.
    Barbou, F.
    Juhan-Vague, I.
    Alessi, M. C.
    Bonnet, J. L.
    EUROPEAN HEART JOURNAL, 2005, 26 : 480 - 480
  • [28] Comparison between initial and chronic response to clopidogrel therapy after coronary stenting for acute coronary syndrome and influence on clinical outcomes
    Cuisset, Thomas
    Quilici, Jacques
    Loosveld, Marie
    Gaborit, Benedicte
    Grosdidier, Charlotte
    Fourcade, Laurent
    Gil, Jean-Marie
    Moro, Pierre Julien
    Morange, Pierre-Emmanuel
    Bonnet, Jean-Louis
    Alessi, Marie-Christine
    AMERICAN HEART JOURNAL, 2012, 164 (03) : 327 - 333
  • [29] Effect of tegoprazan on temporal variability of platelet reactivity in patients treated with clopidogrel after coronary stenting
    Lee, Oh-Hyun
    Roh, Ji Woong
    Kim, Yongcheol
    Im, Eui
    Cho, Deok-Kyu
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2025,
  • [30] Effect of Shexiang baoxin pills on clopidogrel resistance in patients with acute coronary syndrome
    Zhang, Li
    Liu, Na
    Zhang, Jinying
    Zhang, Hui
    PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 29 (06) : 2303 - 2306
12345